Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hoshi Iryo-Sanki CoTSE:7634 85 5-Year Yield-on-Cost % is 2.86 as of Aug. 04, 2026, which is 29% above its 10-year median of 2.22. GuruFocus rates TSE:7634 with a GF Score™ of 85/100 and a GF Value™ of 円4,746.93 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, Hoshi Iryo-Sanki Co ranks worse than 59.42% on this metric.
Hoshi Iryo-Sanki Co's yield on cost for the quarter that ended in Mar. 2026 was 2.86.
The historical rank and industry rank for Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:7634'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.21 Med: 2.22 Max: 3.17
Current: 2.86
During the past 13 years, Hoshi Iryo-Sanki Co's highest Yield on Cost was 3.17. The lowest was 1.21. And the median was 2.22.
TSE:7634's 5-Year Yield-on-Cost % is ranked worse than 59.42% of 69
companies
in the Medical Distribution industry
Industry Median: 3.22
vs TSE:7634: 2.86
Hoshi Iryo-Sanki Co (TSE:7634) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hoshi Iryo-Sanki Co 5-Year Yield-on-Cost % Related Terms
TSE:7634 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoshi Iryo-Sanki Co 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % falls into.
Hoshi Iryo-Sanki Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Hoshi Iryo-Sanki Co (TSE:7634) has a 5-Year Yield-on-Cost % of 2.86 as of Aug. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hoshi Iryo-Sanki Co and its competitors. This is 29% above median its historical median of 2.22. Over the past decade, Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % has ranged from 1.21 to 3.17. According to the industry distribution chart, Hoshi Iryo-Sanki Co ranks #41 out of 69 companies in the Medical Distribution industry, placing it in the top 59.4%.
Is Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % too high?
Hoshi Iryo-Sanki Co's current 5-Year Yield-on-Cost % of 2.86 is 29% above median its 10-year median of 2.22. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 3.17. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.22. Hoshi Iryo-Sanki Co's value of 2.86 is 11.2% below this industry median. Based on the distribution chart, Hoshi Iryo-Sanki Co ranks #41 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hoshi Iryo-Sanki Co ranks #41 out of 69 companies for 5-Year Yield-on-Cost %. This places Hoshi Iryo-Sanki Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.22. Hoshi Iryo-Sanki Co's value of 2.86 is 11.2% below this benchmark. Historically, Hoshi Iryo-Sanki Co's own 5-Year Yield-on-Cost % has ranged from 1.21 to 3.17 over the past decade. While the company's 10-year median is 2.22 vs. the industry median of 3.22, Hoshi Iryo-Sanki Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.22, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoshi Iryo-Sanki Co's current 5-Year Yield-on-Cost % of 2.86 is 11.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hoshi Iryo-Sanki Co and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoshi Iryo-Sanki Co's current 5-Year Yield-on-Cost % is 2.86, which is 29% above median its own 10-year median of 2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,746.93, compared to a current price of 円5,300.00 — trading 11.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.86, which is 29% above median its 10-year median of 2.22 and 11.2% below the Medical Distribution industry median of 3.22. Hoshi Iryo-Sanki Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current 5-Year Yield-on-Cost % is 2.86 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued.
The current stock price of 円5,300.00 is trading 11.7% above its estimated GF Value™ of 円4,746.93.
GuruFocus considers Hoshi Iryo-Sanki Co to be Modestly Overvalued.
Key valuation signals for TSE:7634:
5-Year Yield-on-Cost %: 2.86 (29% above median its 10-year median of 2.22)
GF Value™: 円4,746.93 vs. price of 円5,300.00 (11.7% above fair value)
Industry Position: 11.2% below the Medical Distribution median (#41 of 69)
No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
85GF Score
Get the complete analysis for TSE:7634
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7634 has been successfully added to your 
